logo

XBIO

Xenetic Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

XBIO fundamentals

Xenetic Biosciences (XBIO) released its earnings on Aug 12, 2025: revenue was 589.90K (YoY -18.79%), missed estimates; EPS was -0.45 (YoY +45.78%), missed estimates.
Revenue / YoY
589.90K
-18.79%
EPS / YoY
-0.45
+45.78%
Report date
Aug 12, 2025
EPS
Revenue

Revenue & Expenses

XBIO has released its 2025 Q3 earnings report, with revenue of 1.03M, reflecting a YoY change of 67.19%, and net profit of -509.94K, showing a YoY change of -16.78%. The Sankey diagram below clearly presents XBIO's revenue sources and cost distribution.

Key Indicators

Xenetic Biosciences (XBIO) key financial stats and ratios, covering profitability, financial health, and leverage.
Xenetic Biosciences (XBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Xenetic Biosciences (XBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Xenetic Biosciences (XBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Xenetic Biosciences (XBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Xenetic Biosciences (XBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield